Pericyte angiopoietin2 and neonatal intracranial hemorrhage
周细胞血管生成素2与新生儿颅内出血
基本信息
- 批准号:10288547
- 负责人:
- 金额:$ 46.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsANGPT2 geneAgeAgonistAngiopoietin-2AngiopoietinsApoptosisBasement membraneBindingBiological AssayBlood - brain barrier anatomyBlood VesselsBlood capillariesBrainBrain hemorrhageCASP5 geneCell ProliferationCellsCellular MorphologyCerebral PalsyCerebral hemisphere hemorrhageCognitive deficitsCollectionComplicationConditioned Culture MediaEmbryoEndothelial CellsEpendymaEpigenetic ProcessFollow-Up StudiesFoundationsFutureGene DeletionGoalsGrantHDAC2 geneHemorrhageHistone AcetylationHistone DeacetylaseHumanImmunohistochemistryIntracranial HemorrhagesLeadLigandsMADH2 geneMediatingMessenger RNAMicroRNAsMorbidity - disease rateMusNeonatalNeuraxisNeuronsPathogenesisPericytesPerinatal subependymal hemorrhagePermeabilityPhenotypePlayPopulationPregnancyPremature InfantProteinsProteomicsPublishingRNA Polymerase IIRegulationReportingRoleSamplingSignal TransductionSmall Interfering RNATEK geneTGF-beta type I receptorTIMP3 geneTestingTight JunctionsTissuesTranscriptTransforming Growth Factor betaTransforming Growth FactorsTransgenic MiceTubeVentricularblood-brain barrier disruptionblood-brain barrier permeabilizationbrain endothelial cellchromatin immunoprecipitationexperimental studyfollow-upgene repressionhistone deacetylase 2human RNA sequencinginsightintraventricular hemorrhageknock-downmigrationmortalitymutantnovel strategiesnovel therapeutic interventionnovel therapeuticspreventpromoterreceptorstemtranscriptomicswhite matter
项目摘要
Project Summary / Abstract
Intraventricular hemorrhage (IVH) is a debilitating condition at any age but is especially common and
devastating in premature infants as it is associated with substantial long-term morbidity (e.g., cerebral palsy,
cognitive deficits) and mortality in this population. In premature infants, most IVH stems from hemorrhage in
the germinal matrix (GM), a collection of highly vascularized neuronal and glial precursor located underneath
the ventricular ependyma. Pericytes (PCs) and endothelial cells (ECs) are key components of the blood-brain
barrier (BBB). In the GM, reduction in the numbers of PCs and levels of the ligand transforming growth factor
(TGF)-β1 in comparison to the white matter and cortex has been implicated in the high propensity of the GM to
hemorrhage. Indeed, we previously reported that deletion of the gene encoding activin receptor-like kinase 5
(ALK5), a type I TGFβ receptor, in PCs leads to gross GM hemorrhage (GMH)-IVH in embryonic mice (Dev
Cell, 44:665) largely through effects on ECs. However, mechanisms underlying these non-cell autonomous
effects on ECs are incompletely defined. To search for PC-derived factors that may signal to ECs, we
conducted bulk RNA-sequencing of human brain PCs with and without both siRNA Alk5 knockdown and
TGFβ1 treatment and identified the secreted factor angiopoietin (Angpt) 2. ANGPT2, which is broadly
implicated in EC tube destabilization and/or remodeling, is predominantly expressed by ECs, but PC
expression has not been reported. Moreover, the role ANGPT2, and certainly PC-derived ANGPT2, in GMH-
IVH has not been studied. Follow-up studies confirmed that TGFβ1 treatment of human brain PCs rapidly and
robustly down-regulates levels of Angpt2 mRNA (~65% and ~90% reduction in 3 h and 12 h, respectively) and
protein in an ALK5-dependent manner. This rapid reduction in Angpt2 mRNA suggests agonist-induced
transcript destabilization, which we will investigate in the proposed experiments. Furthermore, chromatin
immunoprecipitation assays revealed that TGFβ1 treatment of PCs promotes epigenetic and transcriptional
repression of Angpt2, increasing histone deacetylase-2 binding and reducing histone acetylation (H3K9ac,
H3K27ac) and RNA polymerase II binding to the proximal promoter. Finally, in mice with Alk5 deletion in PCs,
perivascular ANGPT2 expression is markedly increased. Thus, we hypothesize that when TGFβ-ALK5
signaling in PCs is disrupted, ANGPT2 levels are increased, destabilizing ECs and leading to disruption of the
BBB and GMH-IVH. We will use cultured human brain vascular cells, transgenic mice, proteomic and
3’UTR/microRNA screens and de-identified human brain samples to test this hypothesis in two specific aims:
1) determine mechanisms of TGFβ-mediated regulation of Angpt2 in PCs and effects on ECs; and 2) elucidate
role of PC ANGPT2 in GMH-IVH of mice and humans. This R21 will yield key insights into BBB formation and
GMH-IVH pathogenesis and form the foundation of a subsequent high impact R01 grant that will provide
concrete steps towards devising novel therapeutic strategies for brain hemorrhage.
项目概要/摘要
脑室内出血(IVH)在任何年龄段都是一种使人衰弱的疾病,但尤其常见且
对早产儿来说是毁灭性的,因为它与大量的长期发病有关(例如脑瘫,
在早产儿中,大多数 IVH 源于出血。
生发基质 (GM),是位于下方的高度血管化的神经和神经胶质前体的集合
心室室管膜(PC)和内皮细胞(EC)是血脑的关键组成部分。
在 GM 中,PC 数量和配体转化生长因子水平减少。
与白质和皮质相比,(TGF)-β1 与 GM 的高倾向有关
事实上,我们之前报道过编码激活素受体样激酶5的基因缺失。
PC 中的 I 型 TGFβ 受体 (ALK5) 会导致胚胎小鼠出现严重 GM 出血 (GMH)-IVH (Dev
Cell,44:665)主要是通过对 EC 的影响,然而,这些非细胞自主的机制。
对 EC 的影响尚未完全确定。为了寻找可能向 EC 发出信号的 PC 衍生因素。
对人脑 PC 进行了批量 RNA 测序,有或没有 siRNA Alk5 敲低和
TGFβ1 治疗并鉴定出分泌因子血管生成素 (Angpt) 2。ANGPT2,广泛应用于
涉及 EC 管不稳定和/或重塑,主要由 EC 表达,但 PC
此外,ANGPT2(当然还有 PC 衍生的 ANGPT2)在 GMH- 中的表达尚未见报道。
IVH尚未被研究证实TGFβ1能快速且有效地治疗人脑PC。
强力下调 Angpt2 mRNA 水平(3 小时和 12 小时分别降低约 65% 和约 90%)
Angpt2 mRNA 的这种快速减少表明激动剂诱导的。
转录不稳定,我们将在提议的实验中研究这一点。
免疫沉淀分析表明,TGFβ1 对 PC 的处理可促进表观遗传和转录
抑制 Angpt2,增加组蛋白脱乙酰酶 2 结合并减少组蛋白乙酰化(H3K9ac,
H3K27ac) 和 RNA 聚合酶 II 与近端启动子结合最后,在 PC 中 Alk5 缺失的小鼠中,
因此,当 TGFβ-ALK5 存在时,血管周围 ANGPT2 表达显着增加。
PC 中的信号传导被破坏,ANGPT2 水平升高,破坏 EC 的稳定性并导致
我们将使用培养的人脑血管细胞、转基因小鼠、蛋白质组和 BBB 和 GMH-IVH。
3’UTR/microRNA 筛选和去识别化的人脑样本,以在两个特定目标上检验这一假设:
1) 确定 PC 中 TGFβ 介导的 Angpt2 调节机制以及对 EC 的影响;2) 阐明
PC ANGPT2 在小鼠和人类 GMH-IVH 中的作用,该 R21 将为 BBB 形成和发育提供重要见解。
GMH-IVH 发病机制,并构成后续高影响力 R01 资助的基础,该资助将提供
制定脑出血新治疗策略的具体步骤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Greif其他文献
Daniel Greif的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Greif', 18)}}的其他基金
Epigenetic-mediated Notch pathway activation promotes elastin aortopathy
表观遗传介导的Notch通路激活促进弹性蛋白主动脉病
- 批准号:
10595308 - 财政年份:2023
- 资助金额:
$ 46.06万 - 项目类别:
Novel vascular smooth muscle cell progenitors in development and disease
发育和疾病中的新型血管平滑肌细胞祖细胞
- 批准号:
10433824 - 财政年份:2020
- 资助金额:
$ 46.06万 - 项目类别:
Novel vascular smooth muscle cell progenitors in development and disease
发育和疾病中的新型血管平滑肌细胞祖细胞
- 批准号:
9893632 - 财政年份:2020
- 资助金额:
$ 46.06万 - 项目类别:
Novel vascular smooth muscle cell progenitors in development and disease
发育和疾病中的新型血管平滑肌细胞祖细胞
- 批准号:
10670304 - 财政年份:2020
- 资助金额:
$ 46.06万 - 项目类别:
Vascular disease pathogenesis: the interface of smooth muscle and immune cells
血管疾病发病机制:平滑肌与免疫细胞的界面
- 批准号:
9769127 - 财政年份:2018
- 资助金额:
$ 46.06万 - 项目类别:
Pathological arterial muscularization and the role of integrins
病理性动脉肌化和整合素的作用
- 批准号:
8969702 - 财政年份:2014
- 资助金额:
$ 46.06万 - 项目类别:
Pathological arterial muscularization and the role of integrins
病理性动脉肌化和整合素的作用
- 批准号:
8800479 - 财政年份:2014
- 资助金额:
$ 46.06万 - 项目类别:
Mural cell TGF-beta-mediated signaling and neonatal intracerebral hemorrhage
壁细胞TGF-β介导的信号传导与新生儿脑出血
- 批准号:
8772010 - 财政年份:2014
- 资助金额:
$ 46.06万 - 项目类别:
Morphogenesis of the pulmonary artery smooth muscle layer
肺动脉平滑肌层的形态发生
- 批准号:
8308488 - 财政年份:2008
- 资助金额:
$ 46.06万 - 项目类别:
Morphogenesis of the pulmonary artery smooth muscle layer
肺动脉平滑肌层的形态发生
- 批准号:
8212890 - 财政年份:2008
- 资助金额:
$ 46.06万 - 项目类别:
相似海外基金
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
- 批准号:
10752274 - 财政年份:2024
- 资助金额:
$ 46.06万 - 项目类别:
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
- 批准号:
10668754 - 财政年份:2023
- 资助金额:
$ 46.06万 - 项目类别:
Vector engineering for non-viral delivery of large genomic DNA to the RPE
用于将大基因组 DNA 非病毒传递至 RPE 的载体工程
- 批准号:
10667049 - 财政年份:2023
- 资助金额:
$ 46.06万 - 项目类别:
CRISPR-Cas Editing as a Genetic Cure for Autosomal Dominant Polycystic Kidney Disease
CRISPR-Cas 编辑作为常染色体显性多囊肾病的基因治疗
- 批准号:
10822502 - 财政年份:2023
- 资助金额:
$ 46.06万 - 项目类别:
Development of a novel site-and cell-selective mRNA therapeutic to treat atherosclerosis
开发一种新的位点和细胞选择性 mRNA 治疗剂来治疗动脉粥样硬化
- 批准号:
10679992 - 财政年份:2023
- 资助金额:
$ 46.06万 - 项目类别: